Neurologists' attitudes regarding rt-PA for acute ischemic stroke

Neurology

Volumn 50, Issue 5, 1998, Pages 1491-1494

  Villar Cordova, C ^a   Morgenstern, Lewis B ^a,b   Barnholtz, J S ^c   Frankowski, R F ^c   Grotta, J C ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE;

ADULT; ARTICLE; BRAIN ISCHEMIA; HUMAN; MEDICAL SPECIALIST; NORMAL HUMAN; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; STROKE; TREATMENT OUTCOME; UNITED STATES;

EID: 0031843040     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.50.5.1491     Document Type: Article

References (7)

1. NINDS rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-1587.
2. Quality Standards Subcommittee of the American Academy of Neurology. Practice advisory: thrombolytic therapy for acute ischemic stroke - summary statement. Neurology 1996;47: 835-839.
3. Special Writing Group of the Stroke Council of the American Heart Association. Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke. Stroke 1996;27: 711-718.
4. Lessler DS, Avins AL. Cost, uncertainty, and doctors' decisions: the case of thrombolytic therapy. Arch Intern Med 1992; 152:1665-1672.
5. Fisher LD, Van Belle G. Biostatistics: a methodology for the health sciences. New York: Wiley, 1993.
6. Babbie E. Survey research methods. Belmont, CA: Wadsworth Publishing, 1973.
7. Hlatky MA, Cotugno H, O'Connor C, Mark DB, Pryor DB, Califf RM. Adoption of thrombolytic therapy in the management of acute myocardial infarction. Am J Cardiol 1988;61: 510-514.